News
Royal Cargo passes GDP re-certification audit for pharma logistics
Royal Cargo has announced that its Pharma/Clinical Trial Logistics and Premium Courier Service unit passed the Good Distribution Practices (GDP) re-certification audit.
Pharma Logistics is a business unit of this Philippines-based company that provides Logistics Management Solutions for Pharmaceutical and...
Drug Research
Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials
Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3 driven cancer.
Under the terms...
IT & Data Management
GSK grants exclusive technology license for clinical-stage Ebola vaccines to Sabin Vaccine Institute
GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed...
News
Pharmaceutical Grade Process Equipment Surplus to the needs of Teva Pharmaceuticals
Sale Highlights:
Tank Farm & Distillation Syst.
(35) Assorted Tanks-to 40,000 Liters
Stainless, Plastic, Fiberglass & CS
Assorted Pumps, Filters & Controls
Stainless Pipework, Valves & Work Decks
(2) Vapor Compression H2O Distillation Units, Manufactured by Cor Pharmaceuticals
Factory Infrastructure:
(2)...
News
Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)
Sarepta Therapeutics, Inc, the leader in precision genetic medicine for rare diseases, was informed earlier that an adverse event report was erroneously submitted to the FDA’s adverse event reporting system (FAERs), a post-marketing surveillance database for approved therapies. Our...
Drug Research
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform
Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will use Imagent to create novel therapeutic complexes in four classes of cancer drugs: cytokines, oncolytic viruses, monoclonal antibodies, and nucleic acid constructs.
Vesselon incorporates Imagent...
News
Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
Zenith Capital Corp. announced that Zenith Epigenetics Ltd. , a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara BioPharma Co., Ltd. for the Company’s lead compound, ZEN-3694, in China, Hong Kong, Taiwan, and Macau...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















